Variations in IB1/JIP1 expression regulate susceptibility of β-cells to cytokine-induced apoptosis irrespective of c-Jun NH2-terminal kinase signaling

Diabetes

Volumn 52, Issue 10, 2003, Pages 2497-2502

  Ling, Zhidong ^a,c   Van de Casteele, Mark ^a   Dong, Jing ^a   Heimberg, Harry ^a   Haefliger, Jacques Antoine ^b   Waeber, Gérard ^b   Schuit, Frans ^a   Pipeleers, Daniel ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; ISLET BRAIN 1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INTERACTING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG SYNERGISM; GENE TRANSFER TECHNIQUES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; ISLETS OF LANGERHANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141866863     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.10.2497     Document Type: Article

References (24)

1. Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151, 1998
2. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
3. Hoorens A, Stange G, Pavlovic D, Pipeleers D: Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes 50:551-557, 2001
4. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG: Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340-345, 2000
5. Andersen HU, Larsen PM, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J: Two-dimensional gel electrophoresis of rat islet proteins: interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes 44:400-407, 1995
6. Strandell E, Buschard K, Saldeen J, Welsh N: Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat islet beta-cells, but not in alpha-cells. Immunol Lett 48:145-148, 1995
7. Ling Z, Chen MC, Smismans A, Pavlovic D, Schuit F, Eizirik DL, Pipeleers DG: Intercellular differences in interleukin 1beta-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic beta-cells. Endocrinology 139:1540-1545, 1998
8. Van de Casteele M, Kefas BA, Ling Z, Heimberg H, Pipeleers DG: Specific expression of Bax-omega in pancreatic beta-cells is down-regulated by cytokines before the onset of apoptosis. Endocrinology 143:320-326, 2002
9. Bonny C, Oberson A, Steinmann M, Schorderet DF, Nicod P, Waeber G: IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem 275:16466-16472, 2000
10. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ: A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693-696, 1997
11. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ: A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281:1671-1674, 1998
12. Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, Widmann C, Maillard A, Miklossy J, Dina C, Hani EH, Vionnet N, Nicod P, Boutin P, Froguel P: The gene MAPK8IPI, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24:291-295, 2000
13. Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
14. Ling Z, Hannaert JC, Pipeleers D: Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 37:15-21, 1994
15. Pipeleers DG, Schuit FC, in't Veld PA, Maes E, Hooghe-Peters EL, Van de Winkel M, Gepts W: Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117:824-833, 1985
16. Haefliger JA, Tawadros T, Meylan L, Gurun SL, Roehrich ME, Martin D, Thorens B, Waeber G: The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic beta cells. J Cell Sci 116:1463-1469, 2003
17. Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D: Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574, 1996
18. Bonny C, Nicod P, Waeber G: IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 273:1843-1846, 1998
19. Pipeleers D, Van de Winkel M: Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci U S A 83:5267-5271, 1986
20. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF: Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50:77-82, 2001
21. Barr RK, Kendrick TS, Bogoyevitch MA: Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 277:10987-10997, 2002
22. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D, Van De Casteele M: AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 30:151-161, 2003
23. Taru H, Kirino Y, Suzuki T: Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J Biol Chem 277:27567-27574, 2002
24. Ammendrup A, Maillard A, Nielsen K, Aabenhus Andersen N, Serup P, Dragsbaek Madsen O, Mandrup-Poulsen T, Bonny C: The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 49:1468-1476, 2000